Rhelion Life Sciences TRUFF Stock
Rhelion Life Sciences Price Chart
Rhelion Life Sciences TRUFF Financial and Trading Overview
| Rhelion Life Sciences stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0.02 USD x 2000000 |
| Ask | 0.02 USD x 1000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.005 - 0.04 USD |
| Volume | 13K USD |
| Avg. Volume | 223.76K USD |
| Market Cap | 12.9M USD |
| Beta (5Y Monthly) | 0.962 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TRUFF Valuation Measures
| Enterprise Value | 4.58M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.074013 |
| Price/Book (mrq) | 0.8518202 |
| Enterprise Value/Revenue | 1.091 |
| Enterprise Value/EBITDA | -1.104 |
Trading Information
Rhelion Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.962 |
| 52-Week Change | -22.22% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.005 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
TRUFF Share Statistics
| Avg. Volume (3 month) | 223.76K USD |
| Avg. Daily Volume (10-Days) | 130.9K USD |
| Shares Outstanding | 614.12M |
| Float | 575.17M |
| Short Ratio | N/A |
| % Held by Insiders | 5.90% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1071:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | -145.44% |
| Operating Margin (ttm) | -124.66% |
| Gross Margin | 37.92% |
| EBITDA Margin | -98.80% |
Management Effectiveness
| Return on Assets (ttm) | -15.46% |
| Return on Equity (ttm) | -47.91% |
Income Statement
| Revenue (ttm) | 4.2M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | 3.10% |
| Gross Profit (ttm) | 1.59M USD |
| EBITDA | -4145237 USD |
| Net Income Avi to Common (ttm) | -6101998 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.05M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 1.42M USD |
| Total Debt/Equity (mrq) | 12.65 USD |
| Current Ratio (mrq) | 3.984 |
| Book Value Per Share (mrq) | 0.02465309 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2421528 USD |
| Levered Free Cash Flow (ttm) | -2412329 USD |
Profile of Rhelion Life Sciences
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 1 Adelaide Street East |
| ZIP | M5C 2V9 |
| Phone | 647 204 7129 |
| Website | https://www.rhelion.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rhelion Life Sciences Corp. engages in the research and development of psychedelic drug in Netherlands, Canada, and the United States. Its products also include PEX010, a natural psilocybin drug candidate. It also engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe, as well as selection, distribution, and export of truffles. The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026. Rhelion Life Sciences Corp. is based in Toronto, Canada.
Q&A For Rhelion Life Sciences Stock
What is a current TRUFF stock price?
Rhelion Life Sciences TRUFF stock price today per share is 0.02 USD.
How to purchase Rhelion Life Sciences stock?
You can buy TRUFF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rhelion Life Sciences?
The stock symbol or ticker of Rhelion Life Sciences is TRUFF.
Which industry does the Rhelion Life Sciences company belong to?
The Rhelion Life Sciences industry is Drug Manufacturers - Specialty & Generic.
How many shares does Rhelion Life Sciences have in circulation?
The max supply of Rhelion Life Sciences shares is 614.12M.
What is Rhelion Life Sciences Price to Earnings Ratio (PE Ratio)?
Rhelion Life Sciences PE Ratio is now.
What was Rhelion Life Sciences earnings per share over the trailing 12 months (TTM)?
Rhelion Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the Rhelion Life Sciences company belong to?
The Rhelion Life Sciences sector is Healthcare.
